Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Brazilian (BOVESPA) Drug Retail Industry Analysis

UpdatedJun 15, 2026
DataAggregated Company Financials
Companies4
  • 7D0.3%
  • 3M-25.9%
  • 1Y27.9%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has risen 1.3%, driven by gains from every company within the industry. In the last 12 months, the industry was up 29%. As for the next few years, earnings are expected to grow by 20% per annum.

Industry Valuation and Performance

Has the Brazilian Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 16 Jun 2026R$35.4bR$69.4bR$1.8b13.9x20x0.5x
Thu, 14 May 2026R$39.3bR$69.4bR$1.8b13.6x22.3x0.6x
Sat, 11 Apr 2026R$48.0bR$67.3bR$1.7b19x28.3x0.7x
Mon, 09 Mar 2026R$48.1bR$66.4bR$1.5b26x31.6x0.7x
Wed, 04 Feb 2026R$50.9bR$64.4bR$1.6b27.7x32.6x0.8x
Fri, 02 Jan 2026R$47.1bR$64.4bR$1.6b25.8x30.1x0.7x
Sun, 30 Nov 2025R$46.8bR$64.4bR$1.6b24.6x30x0.7x
Tue, 28 Oct 2025R$37.7bR$62.2bR$1.4b19.9x26.6x0.6x
Thu, 25 Sep 2025R$35.3bR$62.2bR$1.4b19.3x24.9x0.6x
Sat, 23 Aug 2025R$36.0bR$62.2bR$1.4b19.5x25.4x0.6x
Mon, 21 Jul 2025R$26.9bR$60.2bR$1.3b16.8x20.1x0.4x
Wed, 18 Jun 2025R$27.8bR$60.2bR$1.3b16.7x20.8x0.5x
Fri, 16 May 2025R$29.7bR$60.1bR$1.3b18x22.2x0.5x
Sun, 13 Apr 2025R$40.2bR$58.6bR$1.3b21.4x30.2x0.7x
Tue, 11 Mar 2025R$33.8bR$57.8bR$1.5b11.4x22.7x0.6x
Thu, 06 Feb 2025R$37.7bR$56.7bR$1.4b11.4x26.8x0.7x
Sat, 04 Jan 2025R$40.7bR$56.7bR$1.4b11.5x28.9x0.7x
Mon, 02 Dec 2024R$44.9bR$56.7bR$1.4b12.9x31.9x0.8x
Wed, 30 Oct 2024R$45.4bR$54.8bR$1.3b16.9x36.2x0.8x
Fri, 27 Sep 2024R$48.4bR$54.8bR$1.3b16.1x38.6x0.9x
Sun, 25 Aug 2024R$51.7bR$54.8bR$1.3b18.9x41.3x0.9x
Tue, 23 Jul 2024R$48.3bR$53.1bR$1.2b29.7x39.9x0.9x
Thu, 20 Jun 2024R$45.6bR$53.1bR$1.2b27.6x37.7x0.9x
Sat, 18 May 2024R$50.8bR$53.1bR$1.2b20.2x40.7x1x
Mon, 15 Apr 2024R$48.8bR$51.4bR$1.2b30.9x41.7x1x
Wed, 13 Mar 2024R$49.2bR$51.2bR$1.2b31.8x42.2x1x
Fri, 09 Feb 2024R$47.0bR$49.8bR$1.1b20.4x44.4x0.9x
Sun, 07 Jan 2024R$54.7bR$49.8bR$1.1b22x51.7x1.1x
Tue, 05 Dec 2023R$52.0bR$49.8bR$1.1b20.5x49.1x1x
Thu, 02 Nov 2023R$47.4bR$49.3bR$997.0m19.1x47.5x1x
Sat, 30 Sep 2023R$50.3bR$48.1bR$948.8m21.1x53x1x
Mon, 28 Aug 2023R$50.3bR$48.1bR$948.8m22.8x53x1x
Wed, 26 Jul 2023R$53.0bR$46.0bR$1.1b23.3x49.9x1.2x
Fri, 23 Jun 2023R$53.4bR$46.0bR$1.1b21.8x50.3x1.2x
Price to Earnings Ratio

50.3x


Total Market Cap: R$53.4bTotal Earnings: R$1.1bTotal Revenue: R$46.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Drug Retail Industry Price to Earnings3Y Average 35.4x202420252026
Current Industry PE
  • Investors are pessimistic on the Brazilian Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 20.2x which is lower than its 3-year average PE of 35.5x.
  • The industry is trading close to its 3-year average PS ratio of 0.81x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have grown 19% per year over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Brazilian Drug Retail compare with similar industries?

BR Market1.46%
Consumer Staples1.14%
Food and Staples Retail-1.63%
Drug Retail0.29%
Big Box Super Stores-4.67%
Food Retail-7.74%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PNVL3 Dimed Distribuidora de MedicamentosR$11.103.2%
+R$50.7m		33.3%PE12.5x

Latest News

RADL3
R$17.29
Raia Drogasil
7D
-4.5%
1Y
25.0%
Narrative Update • Jun 13

RADL3: Slightly Lower Multiple Will Shape A More Balanced Outlook

Analysts have trimmed their Raia Drogasil price target slightly to around R$19.32 from about R$19.78, reflecting updated assumptions on discount rate, revenue growth, profit margin, and future P/E. What's in the News No recent company specific news items or key developments were provided in the sources above.
PGMN3
R$3.86
Empreendimentos Pague Menos
7D
-4.7%
1Y
12.2%
PNVL3
R$11.10
Dimed Distribuidora de Medicamentos
7D
3.2%
1Y
33.3%
Narrative Update • Jun 04

PNVL3: 2026 Shareholder Meetings Will Support Confident Repricing Case

Analysts have trimmed their price target on Dimed Distribuidora de Medicamentos slightly from R$18.80 to R$18.60, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E levels. What's in the News Dimed Distribuidora de Medicamentos has scheduled a Special and Extraordinary Shareholders Meeting for April 30, 2026, at Avenida Industrial Belgraf 865, Eldorado do Sul, Rio Grande do Sul, Brazil.
DMVF3
R$6.81
d1000 Varejo Farma Participações
7D
-3.8%
1Y
39.0%